Travel Awards for PhD and MD/PhD students and post-doctoral/medical/clinical fellows [next due date 15-May-2019]
The Travel Awards program to support PhD or MD/PhD students and post-doctoral/medical/clinical fellows to present data at a conference, symposium or other appropriate professional meeting will be launched April 1st for the May 15, 2019 deadline.
There are normally three competitions each year:
|1st Competition||2nd Competition||3rd Competition|
|Funding start |
|April 1||August 1||December 1|
For those seeking support to attend the Canadian Cancer Research Conference in Ottawa in November this year, please apply for funding during this round (see eligible conference dates for this program).
The Canadian Institutes of Health Research Institute of Cancer Research (ICR) and Institute of Neurosciences, Mental Health and Addiction (INMHA), in partnership with the Canadian Cancer Society, will support Research investigating the benefits and/or harms related to therapeutic use of cannabis in people living with cancer.
See CIHR grant page HERE
The Cannabis Research in Priority Areas Team Grants is expected to:
- •Generate new scientific knowledge that will advance our understanding of the potential benefits and/or harms of cannabis and/or cannabis use, and impact policies and programs in this area
- Encourage interdisciplinary collaborations, including from across health research and from domains outside of health research, and the sharing of data and resources
- Enhancing capacity development and training in cannabis research
- Connect to existing knowledge translation efforts across Canada, for example through MHCC or the Canadian Centre on Substance Use and Addiction (CCSA)
The maximum amount per grant is $300,000 per year for up to 5 years for a total of $1.5 million, per grant. $1.5 million is available to fund an application relevant to the Cancer Pool (sponsored by the Canadian Cancer Society, ICR, and INMHA).
LOI due date: May 15, 2019
LOI notice of decision: July 15, 2019
Full application deadline: October 8, 2019
Funding start date: January 1, 2020
All applications must be submitted through CIHR’s ResearchNet. For more information view the funding opportunity details on the CIHR website.
CIHR will be hosting webinar(s) to review with participants the requirements of this funding opportunity and to answer questions. To find out more information and to register, visit the Webinars page.
The goal of the CCS/CIHR Cancer Survivorship Team Grant program is to improve the health outcomes for cancer survivors of all ages (pediatric, adolescent, young adult and adult) from the time of their cancer diagnosis until the time of their death or entry into palliative care. This program is not intended to focus on improving end-of-life care.
The intent of this funding opportunity is to support new intervention research designed to mitigate the challenges experienced along the survivorship journey, as well as the evaluation and validation of existing interventions to assess their potential for implementation as best practices.
The program goal will be achieved through the support of a network of multidisciplinary teams, each led by a nominated Principal Investigator and at least 2 co-Principal and/or co- Investigators, one of whom must be within their first five years as an independent researcher, drawn from at least 3 different regions of Canada (Atlantic Provinces, Central Canada, Prairie Provinces, West Coast, Northern Territories). Survivors and caregivers are expected to be engaged as full and active members of research teams.
Teams may request up to $500,000 per year for a maximum of $2,500,000 over a five-year period. Grants will be non-renewable. As the total budget for this competition is $10 million, it is anticipated that at least 4 teams will be funded in this competition. The engagement of additional partners may increase this number.
Registration due date: May 29, 2019
Relevance review results: mid-June, 2019
Full application deadline: September 10, 2019
Results announcement : November 2019
Anticipated start date: December 1, 2019
All applications must be submitted through the online application system (EGrAMS) by 5p.m. EST on the deadline date. Submissions will not be accepted beyond these times.
A Webinar is planned to explain the application process and overall objectives of the call. Applicants can register by sending an email at firstname.lastname@example.org. Details for the April 8th, 2019 (@1pm EST) webinar will be provided in advance to interested applicants.
BioCanRx Call for Letter of Intent – Bench to Bedside Translation of Innovative Cancer Biotherapeutics
Bench to Bedside Translation of Innovative Cancer Biotherapeutics
BioCanRx, Canada’s Immunotherapy Network, is pleased to announce its 2019 Call for Letters of Intent. Selected Letters of Intent will be featured in the Scientific Program of our Cycle II application going forward for review in July 2019 to the federal government’s Networks of Centres of Excellence (NCE) Program.
Building on previous BioCanRx investments in Cycle I, the overarching goal of the Cycle II Research Program will focus on extending immunotherapy successes in the clinic beyond initial responders. To address this challenge, while making use of technologies in the BioCanRx pipeline or by soliciting new complimentary technology, BioCanRx will invest in projects aimed at understanding patient and/or tumour type limitation(s) and proposing improved novel therapies, trials, or combination approaches to overcome the identified limitation(s)
Applications must be received by Wednesday, May 1, 2019.
Full details at https://biocanrx.com/research/research-program-renewal
THE CANCER RESEARCH SOCIETY IS PLEASED TO ANNOUNCE A NEW FUNDING PROGRAM: Translational Research Partnership Program
*** Pour le français, voir plus bas ***
THE CANCER RESEARCH SOCIETY IS PLEASED TO ANNOUNCE A NEW FUNDING PROGRAM
Translational Research Partnership Program
In addition to its regular funding programs, the Cancer Research Society is pleased to support high-impact translational projects throughout Canada. Our aim is to work in collaboration with partners to co-fund bold research projects in order to accelerate the development of new and innovative treatments or medical devices for the benefit of patients.
For more information on this new program, we invite you to visit our website: https://www.societederecherchesurlecancer.ca/en/researchers/translational-research-partnership
Programme de partenariat de recherche translationnelle
Programme de partenariat de recherche translationnelle
En plus de ses programmes de financement réguliers, la Société de recherche sur le cancer a plaisir d’appuyer des projets de recherche translationnelle à haut impact au Canada. L’objectif est de travailler en collaboration avec des partenaires pour cofinancer des projets de recherche audacieux afin d’accélérer le développement de nouvelles approches thérapeutiques ou de technologies médicales innovantes au bénéfice des patients.
Pour plus d’information sur ce nouveau programme, nous vous invitons à consulter notre site web. https://www.societederecherchesurlecancer.ca/fr/chercheurs/partenariat-de-recherche-translationnelle
Scholarships for the Next Generation of Scientists Competition [$50,000 PDF + $120,000 operating grant]
Please forward this message to all postdoctoral fellows interested in pursuing a career in cancer research in Canada.
The Cancer Research Society is pleased to announce the launch of its 2019 Scholarships for the Next Generation of Scientists competition, an initiative aiming at supporting future generations of Canadian researchers. The Scholarship is broken down into two parts, and extends over a period of 3 years, with no possibility for renewal.
Deadlines for submitting an application: April 26, 2019, 11:59 pm (EST).
Part 1: Postdoctoral Salary Award – 1 year * – $50,000 One year postdoctoral salary award for a candidate finishing his/her fellowship. The candidate must have completed at least two years of postdoctoral training at the time he/she accepts the salary award.
* Possibility of extending Part 1 of this award for a maximum period of 6 months.
Part 2: Operating Grant – 2 years – $120,000 ($60,000/year) Operating grant award once the candidate has obtained a faculty position at a recognized Canadian institution.
You have two options for submitting your application.
- Sending your application and accompanying documents using the button provided on our website. The deadline for submitting your electronic files is April 26 2019, 11:59 pm (EST).
- Saving on two (2) CDs or two (2) USB keys and sending it by mail or courier, as per the instructions on our website. The deadline for mailing your application is April 26, 2019. Applications must be postmarked on or before this date.
For additional information on the competition, please visit our website.
For all questions, please contact Lucille Beaudet or Irina Navarrete at email@example.com or, toll free, 1 888-766-2262.
Lucille BeaudetDirector, Scientific Affairs
Attention Brain Tumor Researchers! Funding opportunity “Improving Outcomes for Pediatric, Adolescent and Young Adult Cancer Survivors”. LOI due 15-Feb-2019 and 15-Dec-2019
NCI is now accepting applications for the funding opportunity “Improving Outcomes for Pediatric, Adolescent and Young Adult Cancer Survivors” (RFA-CA-19-033**).
The full request for applications (RFA) is available here.
This RFA aims to develop and test interventions that prevent, mitigate, or manage adverse outcomes in pediatric and/or AYA cancer survivors and/or evaluate models of care that strengthen coordination, continuity, and quality, or that reduce access barriers to needed services including follow-up care, and that improve outcomes across the survivor’s lifespan.
This RFA is associated with the Childhood Cancer Survivorship, Treatment, Access, and Research (STAR) Act of 2018 that is intended to maximize and accelerate discovery, development, and availability of promising childhood cancer treatments. National Brain Tumor Society (NBTS) is proud to be one of a handful of pediatric cancer organizations who convened to identify, coordinate, and prioritize the needs of the pediatric cancer population which led to the STAR Act.
Applications are encouraged that address any of the following areas relevant to pediatric and AYA cancer survivors, as outlined in the STAR Act:
- Outcomes and/or Barriers to follow-up care, including within minority or other medically underserved populations and with respect to health disparities
- The impact of relevant factors, which may include familial, socioeconomic, and other environmental factors, on treatment outcomes and survivorship
- The development of indicators used for long-term follow-up and analysis of the late effects of cancer treatment
- The identification of risk factors associated with late effects of treatment; predictors of adverse neurocognitive and psychosocial outcomes; and the molecular basis of long-term and late complications
- The development of targeted interventions to reduce the burden of morbidity borne by cancer survivors to protect such cancer survivors from the late effects of cancer or its treatment
Working with our brain tumor advocates, NBTS coordinated hundreds of meetings with congressional offices to share the importance of this bill and encourage Member support. Because of the devoted efforts from volunteer advocates, and the collaboration across many pediatric cancer organizations, the STAR Act became law in record time and will have a lasting impact on the pediatric brain tumor population.
Thank you for your ongoing dedication to the needs of brain tumor patients and their families.
National Brain Tumor Staff and Board
** RFA-CA-19-033 is also associated with the Beau Biden Cancer MoonshotSM Initiative that is intended to accelerate cancer research.
CADTH Symposium Travel Award Program for Students and Patient Group Representatives – apply by 10-Dec-2018
CADTH is pleased to announce the 2019 CADTH Symposium Travel Award Program for students and patient group representatives.
Since 2007, CADTH has provided financial support toward conference-related costs for more than 335 student and patient group representatives as part of our commitment to making this important event accessible to all health care stakeholders.
This year, eligible students and patient group representatives can receive up to $2,000 to offset registration, travel, food, accommodation, and other conference-related expenses.
The 2019 CADTH Symposium offers an excellent opportunity to share your research, learn about the latest advancements in health technology assessment, and interact with peers from across the country as well as leading Canadian and international experts. If you’re a full-time undergraduate or graduate student attending a degree-granting institution in Canada, and taking courses in a field relevant to CADTH’s work, we invite you to apply for a travel award.
For Patient Group Representatives
It’s important that your voice is heard. If you work for a not-for-profit, patient-related organization, or a citizen’s organization interested in health policy, we invite you to apply for a travel award.
How to Apply
Step 1: Review the 2019 CADTH Symposium Travel Award Program Criteria.
Step 2: Complete and submit the 2019 Travel Awards Application form to CADTH by December 10, 2018.
Travel award decisions will be made by the end of January 2019, and awards will be issued to successful applicants by the end of March 2019.
Reminder: The Abstract Submission Deadline for the 2019 CADTH Symposium is October 26, 2018. Priority will be given to Travel Award applicants who have submitted an abstract for the 2019 CADTH Symposium.
If you have questions about the 2019 CADTH Symposium, or the Travel Award Program, please contact us at firstname.lastname@example.org. We’re looking forward to seeing you in Edmonton in 2019.
CADTH is an independent, not-for-profit organization responsible for providing Canada’s health care decision-makers with objective evidence to help make informed decisions about the optimal use of drugs and medical devices in our health care system. CADTH receives funding from Canada’s federal, provincial, and territorial governments, with the exception of Quebec.
Learn more at: www.cadth.ca.
CIHR Request for Applications: Transitions in Care Team Grant | Subventions d’équipe Transitions dans les soins
CIHR, on behalf of the Transitions in Care (TiC) multi-Institute strategic initiative and its associated Institutes, is pleased to announce the launch of the TiC Team Grants. The focus of this funding opportunity is to support inter-disciplinary teams that are poised and ready to address transition in care challenges to optimize patient outcomes. The grants will provide funds to implement, evaluate, spread, and scale pragmatic solutions to problems associated with transitions in care from a clinical, health care and/or health system perspective.
This funding opportunity will support applications centered on the intersection of two or more TiC focus areas.
There are two (2) application streams for this funding opportunity:
- Stream 1: PHSI solutions for transitions in care gaps
- Stream 2: eHIPP solutions for transitions in care gaps
- Program Launch: August 30, 2018
- Application Deadline: January 24, 2019
- Notice of Decision: April 2019
- Funding Start Date: April 1, 2019
- The total CIHR amount available for this funding opportunity is $9.6 million enough to fund approximately ten (10)
- The maximum CIHR amount per grant is $240,000 per year for up to four (4) years for a total of$960,000 per grant.
- Applicants must secure, by the application deadline, partnership contributions equivalent to a minimum of 30% of the total grant amount requested, with a minimum of half of the amount representing a cash contribution (i.e., a total of $288,000 partner match required per grant with minimum of $144,000 as a cash contribution per grant), for a total grant value of up to $1.248 million per grant over four (4) years.
Partner Linkage Tool
CIHR has launched an on-line linkage tool designed to assist researchers and other stakeholders in identifying and connecting with potential partners to develop their projects. The goal of this tool is to allow potential applicants, knowledge users and partners with the ability to connect to see if synergies can be leveraged in the development of research ideas and applications. This tool should be completed by organizations (e.g. health information technology companies, health authorities, hospitals, etc.), researchers and other individuals (patients, health care professionals, etc.) who have an interest in connecting with others in relation to the Transitions in Care Team Grants . The information provided will be posted on CIHR’s web page.
To learn more
The complete funding opportunity is now live on ResearchNet.
CIHR Contact Centre
Toll Free: 1-888-603-4178
Appel de demandes : subventions d’équipe Transitions dans les soins
Les IRSC, au nom de l’initiative stratégique interinstituts Transitions dans les soins (TS) et de ses instituts associés, sont heureux d’annoncer le lancement des subventions d’équipe TS. Cette possibilité de financement vise essentiellement à soutenir des équipes interdisciplinaires qui sont disposées et prêtes à optimiser les résultats pour les patients des transitions dans les soins. Les fonds octroyés permettront de mettre en œuvre, d’évaluer, de diffuser et de mettre à l’échelle des solutions pragmatiques aux problèmes liés aux transitions dans les soins selon une perspective clinique, de soins de santé et/ou de système de santé.
Domaines de recherche
Cette possibilité de financement vise à soutenir des projets centrés sur le recoupement d’au moins deux des secteurs d’intervention privilégiés de l’initiative TS.
Volets de recherche
La présente possibilité de financement comporte deux volets :
- Volet 1 : solutions PASS pour les transitions dans les soins
- Volet 2 : solutions PPIC pour les transitions dans les soins
- Lancement du programme : 30 août 2018
- Date limite de présentation des demandes : 24 janvier 2019
- Diffusion de l’avis de décision : avril 2019
- Date du début du financement : 1er avril 1 2019
- Le montant total disponible dans le cadre de cette possibilité de financement est de 9,6 millions de dollars, ce qui devrait permettre de financer une dizaine de subventions.
- La somme maximale accordée par les IRSC par subvention et par année est de 240 000 $ pour au plus quatre ans, soit un total de 960 000 $ par subvention.
- Les candidats doivent, d’ici la date limite de présentation des demandes, obtenir une contribution partenariale équivalant à un minimum de 30 % de la valeur totale de la subvention demandée, et au moins la moitié de cette somme doit être une contribution en espèces (c.-à-d. que 288 000 $ au total par subvention doivent provenir de partenaires, dont un minimum de 144 000 $ en espèces), pour un total de 1 248 000 $ par subvention pendant quatre ans.
Outil d’établissement de liens
Les IRSC ont lancé un outil d’établissement de liens en ligne conçu pour aider les chercheurs et autres parties concernées à échanger avec des partenaires éventuels en vue de développer des projets. L’objectif de cet outil est de permettre aux utilisateurs de connaissances, partenaires et candidats potentiels d’entrer en contact afin de tirer parti des synergies ainsi créées pour pousser plus loin leurs idées de recherche. Cet outil devrait être utilisé par des organisations (p. ex. sociétés de technologie de l’information sur la santé, autorités sanitaires, hôpitaux), des chercheurs et d’autres personnes (patients, professionnels de la santé, etc.) qui souhaitent établir des contacts relativement aux subventions d’équipe de l’initiative Transitions dans les soins. L’information fournie sera publiée sur une page Web des IRSC.
Pour en savoir plus
La version intégrale de la possibilité de financement est maintenant accessible en ligne dans RechercheNet.
Centre de contact des IRSC
Numéro sans frais : 1-888-603-4178
Are you working in LMIC or an international project? Astellas Oncology C3 Prize applications due July 31, 2018
Astellas Oncology is inviting healthcare innovators to propose ideas that address specific challenges encountered in low- and middle-income countries within the following three categories: support tools, educational tools and technology. The three category winners will be flown to Kuala Lumpur to compete in a live pitch before a panel of judges at the Union for International Cancer Control (UICC) World Cancer Congress on October 3, 2018. Please see www.astellas.ca/Uploads/pdf/C3%20Prize%20Launch%20Release%20FINAL%2004%2021%2016.pdf
Following the live pitch, prizes totaling $100,000 USD will be awarded to the three winners – one $50,000 USD grand prize and two $25,000 USD grants. Winners will also receive a one-year “nights and weekends” membership to MATTER, a Chicago-based healthcare innovation community, to help bring their ideas to life. More information about the awards and submission criteria, including full terms and conditions and eligibility, can be found at: www.c3prize.com. Entries will be accepted through July 25, 2018.
If you have any questions, feel free to reach out to Courteney Bone [Courteney.Bone@energipr.com] via email or phone 416-425-9143 x203.